• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

芳烃受体在慢性炎症性皮肤病中的作用:一篇叙述性综述。

Aryl hydrocarbon receptor role in chronic inflammatory skin diseases: a narrative review.

作者信息

Dec Michał, Arasiewicz Hubert

机构信息

Department of Dermatology and Vascular Anomalies, John Paul II Centre of Paediatrics, Sosnowiec, Poland.

出版信息

Postepy Dermatol Alergol. 2024 Feb;41(1):9-19. doi: 10.5114/ada.2023.135617. Epub 2024 Feb 28.

DOI:10.5114/ada.2023.135617
PMID:38533374
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10962376/
Abstract

The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that has gained increasing attention in the field of dermatology due to its multifaceted role in skin health and disease. This review provides a comprehensive overview of the current state of knowledge regarding the AHR and its implications in dermatological conditions. The AHR is well known for its involvement in xenobiotic metabolism, particularly in response to polycyclic aromatic hydrocarbons and dioxins. However, recent research has unveiled its pivotal role in the skin immune response, barrier function, and homeostasis. The AHR signalling pathway is intricately linked to various dermatological disorders, including psoriasis, atopic dermatitis, acne and hidradenitis suppurativa. In this review, we delve into the molecular mechanisms through which AHR activation influences skin physiology and highlight how dysregulation can lead to pathological conditions. Moreover, we discuss the emerging therapeutic potential of AHR modulators in the treatment of skin diseases. In conclusion, the AHR is a pivotal player in dermatology, with a multifaceted role in skin physiology and pathology. Understanding the intricacies of AHR signalling in the skin offers promising avenues for the development of novel therapies and preventive strategies for various dermatological conditions. Further research is warranted to elucidate the full scope of AHR's contributions to dermatology and its potential as a therapeutic target.

摘要

芳基烃受体(AHR)是一种配体激活的转录因子,由于其在皮肤健康和疾病中的多方面作用,在皮肤病学领域受到越来越多的关注。本文综述了目前关于AHR的知识现状及其在皮肤病学中的意义。AHR以参与外源性物质代谢而闻名,尤其是对多环芳烃和二恶英的反应。然而,最近的研究揭示了它在皮肤免疫反应、屏障功能和内环境稳态中的关键作用。AHR信号通路与多种皮肤病密切相关,包括银屑病、特应性皮炎、痤疮和化脓性汗腺炎。在本文综述中,我们深入探讨了AHR激活影响皮肤生理的分子机制,并强调了失调如何导致病理状态。此外,我们还讨论了AHR调节剂在皮肤病治疗中的新兴治疗潜力。总之,AHR是皮肤病学中的关键角色,在皮肤生理和病理中具有多方面作用。了解皮肤中AHR信号的复杂性为开发各种皮肤病的新疗法和预防策略提供了有前景的途径。有必要进行进一步研究,以阐明AHR对皮肤病学的全面贡献及其作为治疗靶点的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ac/10962376/b014191c5359/PDIA-41-52446-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ac/10962376/fa1a8fa6dc42/PDIA-41-52446-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ac/10962376/d62fbcdfc832/PDIA-41-52446-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ac/10962376/cd6cc5d678f8/PDIA-41-52446-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ac/10962376/f2adf1070186/PDIA-41-52446-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ac/10962376/74e9314ac423/PDIA-41-52446-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ac/10962376/b014191c5359/PDIA-41-52446-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ac/10962376/fa1a8fa6dc42/PDIA-41-52446-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ac/10962376/d62fbcdfc832/PDIA-41-52446-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ac/10962376/cd6cc5d678f8/PDIA-41-52446-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ac/10962376/f2adf1070186/PDIA-41-52446-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ac/10962376/74e9314ac423/PDIA-41-52446-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ac/10962376/b014191c5359/PDIA-41-52446-g006.jpg

相似文献

1
Aryl hydrocarbon receptor role in chronic inflammatory skin diseases: a narrative review.芳烃受体在慢性炎症性皮肤病中的作用:一篇叙述性综述。
Postepy Dermatol Alergol. 2024 Feb;41(1):9-19. doi: 10.5114/ada.2023.135617. Epub 2024 Feb 28.
2
Role of Aryl Hydrocarbon Receptor Activation in Inflammatory Chronic Skin Diseases.芳基烃受体激活在炎症性慢性皮肤病中的作用。
Cells. 2021 Dec 16;10(12):3559. doi: 10.3390/cells10123559.
3
Role of AHR Ligands in Skin Homeostasis and Cutaneous Inflammation.AHR 配体在皮肤稳态和皮肤炎症中的作用。
Cells. 2021 Nov 15;10(11):3176. doi: 10.3390/cells10113176.
4
Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis.芳香烃受体在特应性皮炎和银屑病中的作用。
Int J Mol Sci. 2019 Oct 31;20(21):5424. doi: 10.3390/ijms20215424.
5
Tapinarof validates the aryl hydrocarbon receptor as a therapeutic target: A clinical review.他扎罗汀验证了芳烃受体作为治疗靶点的有效性:临床综述。
J Allergy Clin Immunol. 2024 Jul;154(1):1-10. doi: 10.1016/j.jaci.2023.12.013. Epub 2023 Dec 27.
6
Aryl hydrocarbon receptor/nuclear factor E2-related factor 2 (AHR/NRF2) signalling: A novel therapeutic target for atopic dermatitis.芳香烃受体/核因子 E2 相关因子 2(AHR/NRF2)信号通路:特应性皮炎的新治疗靶点。
Exp Dermatol. 2022 Apr;31(4):485-497. doi: 10.1111/exd.14541. Epub 2022 Mar 1.
7
Tapinarof in the treatment of psoriasis: A review of the unique mechanism of action of a novel therapeutic aryl hydrocarbon receptor-modulating agent.他卡西醇治疗银屑病:新型芳香烃受体调节剂独特作用机制的综述。
J Am Acad Dermatol. 2021 Apr;84(4):1059-1067. doi: 10.1016/j.jaad.2020.10.085. Epub 2020 Nov 3.
8
Aryl Hydrocarbon Receptors: Evidence of Therapeutic Targets in Chronic Inflammatory Skin Diseases.芳烃受体:慢性炎症性皮肤病治疗靶点的证据
Biomedicines. 2022 May 7;10(5):1087. doi: 10.3390/biomedicines10051087.
9
Tapinarof, a Novel, First-in-Class, Topical Therapeutic Aryl Hydrocarbon Receptor Agonist for the Management of Psoriasis.他卡西醇,一种新型、首创的、局部用芳香烃受体激动剂,用于治疗银屑病。
J Drugs Dermatol. 2023 Aug 1;22(8):779-784. doi: 10.36849/jdd.7317.
10
Aryl hydrocarbon receptor: current perspectives on key signaling partners and immunoregulatory role in inflammatory diseases.芳烃受体:在炎症性疾病中的关键信号伙伴和免疫调节作用的最新观点。
Front Immunol. 2024 Aug 15;15:1421346. doi: 10.3389/fimmu.2024.1421346. eCollection 2024.

引用本文的文献

1
The AhR pathway is dysregulated in alopecia areata.芳香烃受体(AhR)信号通路在斑秃中失调。
J Transl Autoimmun. 2025 Mar 7;10:100282. doi: 10.1016/j.jtauto.2025.100282. eCollection 2025 Jun.
2
Mutated IL-32θ (A94V) inhibits COX2, GM-CSF and CYP1A1 through AhR/ARNT and MAPKs/NF-κB/AP-1 in keratinocytes exposed to PM.在暴露于颗粒物的角质形成细胞中,突变型白细胞介素-32θ(A94V)通过芳烃受体/芳烃受体核转运蛋白以及丝裂原活化蛋白激酶/核因子κB/活化蛋白-1抑制环氧化酶2、粒细胞-巨噬细胞集落刺激因子和细胞色素P450 1A1。
Sci Rep. 2025 Jan 15;15(1):1994. doi: 10.1038/s41598-024-83159-z.
3
Th Pathways in Immune-Mediated Skin Disorders: A Guide for Strategic Treatment Decisions.

本文引用的文献

1
Vitiligo responds to topical aryl hydrocarbon receptor agonist tapinarof (WBI-1001).白癜风对局部应用芳烃受体激动剂他扎罗芬(WBI-1001)有反应。
JAAD Case Rep. 2023 Jul 26;39:150-151. doi: 10.1016/j.jdcr.2023.06.051. eCollection 2023 Sep.
2
Potential roles of gut microbial tryptophan metabolites in the complex pathogenesis of acne vulgaris.肠道微生物色氨酸代谢产物在寻常痤疮复杂发病机制中的潜在作用。
Front Microbiol. 2022 Jul 27;13:942027. doi: 10.3389/fmicb.2022.942027. eCollection 2022.
3
Tapinarof Cream 1%: First Approval.他卡西醇乳膏 1%:美国批准。
免疫介导性皮肤病的治疗途径:战略治疗决策指南
Immune Netw. 2024 Aug 14;24(5):e33. doi: 10.4110/in.2024.24.e33. eCollection 2024 Oct.
4
Pathogenesis of Inflammation in Skin Disease: From Molecular Mechanisms to Pathology.皮肤疾病炎症的发病机制:从分子机制到病理学。
Int J Mol Sci. 2024 Sep 21;25(18):10152. doi: 10.3390/ijms251810152.
5
[Modern topical drugs-new developments in galenics and pharmacology].[现代局部用药物——药剂学与药理学的新进展]
Dermatologie (Heidelb). 2024 Oct;75(10):753-761. doi: 10.1007/s00105-024-05404-w. Epub 2024 Aug 27.
Drugs. 2022 Jul;82(11):1221-1228. doi: 10.1007/s40265-022-01748-6.
4
One-year safety and efficacy of tapinarof cream for the treatment of plaque psoriasis: Results from the PSOARING 3 trial.他卡西醇乳膏治疗斑块状银屑病 1 年的安全性和疗效:PSOARING 3 试验结果。
J Am Acad Dermatol. 2022 Oct;87(4):800-806. doi: 10.1016/j.jaad.2022.06.1171. Epub 2022 Jun 27.
5
Aryl Hydrocarbon Receptors: Evidence of Therapeutic Targets in Chronic Inflammatory Skin Diseases.芳烃受体:慢性炎症性皮肤病治疗靶点的证据
Biomedicines. 2022 May 7;10(5):1087. doi: 10.3390/biomedicines10051087.
6
New Topical Therapies in Development for Atopic Dermatitis.新型特应性皮炎局部治疗药物的研发进展。
Drugs. 2022 Jun;82(8):843-853. doi: 10.1007/s40265-022-01722-2. Epub 2022 May 21.
7
Role of AHR Ligands in Skin Homeostasis and Cutaneous Inflammation.AHR 配体在皮肤稳态和皮肤炎症中的作用。
Cells. 2021 Nov 15;10(11):3176. doi: 10.3390/cells10113176.
8
Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics.1%他卡西醇乳膏治疗广泛斑块状银屑病:最大剂量安全性、耐受性和药代动力学试验。
Am J Clin Dermatol. 2022 Jan;23(1):83-91. doi: 10.1007/s40257-021-00641-4. Epub 2021 Oct 28.
9
Environmental, inflammatory, and anti-inflammatory squad in acne vulgaris pathogenesis: AhR, IL-36, and IL-38.痤疮发病机制中的环境、炎症和抗炎小队:AhR、IL-36 和 IL-38。
J Cosmet Dermatol. 2022 Jul;21(7):3038-3045. doi: 10.1111/jocd.14542. Epub 2021 Oct 22.
10
Anti-Inflammatory and Pro-Differentiating Properties of the Aryl Hydrocarbon Receptor Ligands NPD-0614-13 and NPD-0614-24: Potential Therapeutic Benefits in Psoriasis.芳基烃受体配体 NPD-0614-13 和 NPD-0614-24 的抗炎和促分化特性:在银屑病中的潜在治疗益处。
Int J Mol Sci. 2021 Jul 13;22(14):7501. doi: 10.3390/ijms22147501.